WHI and WHIMS follow-up and human studies of soy isoflavones on cognition

References

• Brinton RD. A women’s health issue: Alzheimer’s disease and strategies for maintaining cognitive health. Int. J. Fertil. Womens Med.44, 174–185 (1999).
   PubMedGoogle Scholar
• McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res.57, 357–384 (2002).
   PubMedGoogle Scholar
• Shumaker S. Hormone therapy in dementia prevention: the Women’s Health Initiative Memory Study. Neurobiol. Aging17(Suppl. 4), S9 (1996).
   PubMed Web of Science ®Google Scholar
• Rapp SR, Espeland MA, Shumaker SA et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA289, 2663–2672 (2003).
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA289, 2651–2662 (2003).
   PubMed Web of Science ®Google Scholar
• Espeland MA, Rapp SR, Shumaker SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA291, 2959–2968 (2004).
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller LH et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA291, 2947–2958 (2004).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA288(3), 321–333(2002).
   PubMed Web of Science ®Google Scholar
• The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative Randomized Controlled Trial. JAMA291, 1701–1712 (2004).
   PubMed Web of Science ®Google Scholar
• Henderson VW. Estrogen-containing hormone therapy and Alzheimer’s disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience138, 1031–1039 (2006).
   PubMed Web of Science ®Google Scholar
• Yesufu A, Bandelow S, Hogervorst E. Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Women’s Health3, 173–194 (2006).
   Google Scholar
• Zhao L, O’Neill K, Brinton RD. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res. Brain Res. Rev.49, 472–493 (2005).
   PubMedGoogle Scholar
• Sherwin BB. The clinical relevance of the relationship between estrogen and cognition in women. J. Steroid Biochem. Mol. Biol.106, 151–156 (2007).
   PubMed Web of Science ®Google Scholar
• Brinton RD, Nilsen J. Effects of estrogen plus progestin on risk of dementia. JAMA290, 1706 (2003).
   PubMed Web of Science ®Google Scholar
• Brinton RD. Estrogen therapy for prevention of Alzheimer’s disease not for rehabilitation following onset of disease: the healthy cell bias of estrogen action. In: Synaptic Plasticity: Basic Mechanisms to Clinical Applications. Taylor & Francis Group, NY, USA 131–157 (2004).
   Google Scholar
• Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA288, 2123–2129 (2002).
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Henderson VW, Paine BJ et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause13, 28–36 (2006).
   PubMed Web of Science ®Google Scholar
• Matthews K, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J. Am. Geriatr. Soc.47, 518–523 (1999).
   PubMed Web of Science ®Google Scholar
• Steffens DC, Norton MC, Plassman BL et al. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J. Am. Geriatr. Soc.47, 1171–1175 (1999).
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Tang MX, Stern Y et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology50, 368–373 (1998).
   PubMed Web of Science ®Google Scholar
• Baldereschi M, Di Carlo A, Lepore V et al. Estrogen-replacement therapy and Alzheimer’s disease in the Italian Longitudinal Study on Aging. Neurology50, 996–1002 (1998).
   PubMed Web of Science ®Google Scholar
• Waring SC, Rocca WA, Petersen RC, O’Brien PC, Tangalos EG, Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology52, 965–970 (1999).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA297, 1465–1477 (2007).
   PubMed Web of Science ®Google Scholar
• Manson JE, Allison MA, Rossouw JE et al. Estrogen therapy and coronary-artery calcification. N. Engl. J. Med.356, 2591–2602 (2007).
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Cronin KA, Howlader N et al. The decrease in breast-cancer incidence in 2003 in the United States. N. Engl. J. Med.356, 1670–1674 (2007).
   PubMed Web of Science ®Google Scholar
• Kurzer MS, Xu X. Dietary phytoestrogens. Annu. Rev. Nutr.17, 353–381 (1997).
   PubMed Web of Science ®Google Scholar
• Dixon RA. Phytoestrogens. Annu. Rev. Plant Biol.55, 225–261 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao L, Brinton RD. Structure-based virtual screening for plant-based ERβ-selective ligands as potential preventative therapy against age-related neurodegenerative diseases. J. Med. Chem.48, 3463–3466 (2005).
   PubMed Web of Science ®Google Scholar
• De Rijke E, Zafra-Gomez A, Ariese F, Brinkman UA, Gooije C. Determination of isoflavone glucoside malonates in Trifolium pratense L. (red clover) extracts: quantification and stability studies. J. Chromatogr. A932, 55–64 (2001).
   PubMed Web of Science ®Google Scholar
• Mazur W, Adlercreutz H. Naturally occurring oestrogens in food. Pure Appl. Chem.70, 1759–1776 (1998).
   Web of Science ®Google Scholar
• Song TT, Hendrich S, Murphy PA. Estrogenic activity of glycitein, a soy isoflavone. J. Agric. Food Chem.47, 1607–1610 (1999).
   PubMed Web of Science ®Google Scholar
• Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr.40, 569–578 (1984).
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J. Nutr.132, 3577–3584 (2002).
   PubMed Web of Science ®Google Scholar
• Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KD. The identification of the weak oestrogen equol [7-hydroxy-3-(4´-hydroxyphenyl)chroman] in human urine. Biochem. J.201, 353–357 (1982).
   PubMed Web of Science ®Google Scholar
• de Kleijn MJ, van der Schouw YT, Wilson PW et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1–4). J. Nutr.131, 1826–1832 (2001).
   PubMed Web of Science ®Google Scholar
• Maskarinec S. The effect of phytoestrogens on hot flashes. Nutrition Bytes9(2), 5 (2003).
   Web of Science ®Google Scholar
• Ziegler RG. Phytoestrogens and breast cancer. Am. J. Clin. Nutr.79, 183–184 (2004).
   PubMed Web of Science ®Google Scholar
• Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res. Treat.18, S11–S17 (1991).
   PubMed Web of Science ®Google Scholar
• Wu AH, Ziegler RG, Horn-Ross PL et al. Tofu and risk of breast cancer in Asian–Americans. Cancer Epidemiol. Biomarkers Prev.5, 901–906 (1996).
   PubMed Web of Science ®Google Scholar
• Rice MM, LaCroix AZ, Lampe JW et al. Dietary soy isoflavone intake in older Japanese American women. Public Health Nutr.4, 943–952 (2001).
   PubMed Web of Science ®Google Scholar
• Kawano H, Ueda K, Fujishima M. Prevalence of dementia in a Japanese community (Hisayama): morphological reappraisal of the type of dementia. Jpn J. Med.29, 261–265 (1990).
   PubMedGoogle Scholar
• Hasegawa K. The clinical issues of age-related dementia. Tohoku J. Exp. Med.161, 29–38 (1990).
   PubMedGoogle Scholar
• Shibayama H, Kasahara Y, Kobayashi H et al. Prevalence of dementia in a Japanese elderly population. Unusual cases of presenile dementia with Fahr’s syndrome. Acta Psychiatr. Scand.74, 144–151 (1986).
   PubMed Web of Science ®Google Scholar
• Ichinowatari N, Tatsunuma T, Makiya H. Epidemiological study of old age mental disorders in the two rural areas of Japan. Jpn J. Psychiatry Neurol.41, 629–636 (1987).
   PubMedGoogle Scholar
• Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke23, 798–803 (1992).
   PubMed Web of Science ®Google Scholar
• Kiyohara Y, Yoshitake T, Kato I et al. Changing patterns in the prevalence of dementia in a Japanese community: the Hisayama study. Gerontology40, 29–35 (1994).
   PubMed Web of Science ®Google Scholar
• Fukunishi I, Hayabara T, Hosokawa K. Epidemiological surveys of senile dementia in Japan. Int. J. Soc. Psychiatry37, 51–56 (1991).
   PubMedGoogle Scholar
• Liu HC, Chou P, Lin KN et al. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol. Med.24, 763–770 (1994).
   PubMed Web of Science ®Google Scholar
• Li G, Shen YC, Chen CH, Zhao YW, Li SR, Lu M. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr. Scand.79, 557–563 (1989).
   PubMed Web of Science ®Google Scholar
• Zhang MY, Katzman R, Salmon D et al. The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol.27, 428–437 (1990).
   PubMed Web of Science ®Google Scholar
• Wang W, Wu S, Cheng X et al. Prevalence of Alzheimer’s disease and other dementing disorders in an urban community of Beijing, China. Neuroepidemiology19, 194–200 (2000).
   PubMed Web of Science ®Google Scholar
• Bachman DL, Wolf PA, Linn R et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology42, 115–119 (1992).
   PubMed Web of Science ®Google Scholar
• Folstein MF, Bassett SS, Anthony JC, Romanoski AJ, Nestadt GR. Dementia: case ascertainment in a community survey. J. Gerontol.46, 132–138 (1991).
   PubMedGoogle Scholar
• Evans DA, Funkenstein HH, Albert MS et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA262, 2551–2556 (1989).
   PubMed Web of Science ®Google Scholar
• Group CSoHaAW. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can. Med. Assoc. J.150, 899–913 (1994).
   PubMed Web of Science ®Google Scholar
• Brayne C, Calloway P. An epidemiological study of dementia in a rural population of elderly women. Br. J. Psychiatry155, 214–219 (1989).
   PubMed Web of Science ®Google Scholar
• O’Connor DW, Pollitt PA, Hyde JB et al. The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr. Scand.79, 190–198 (1989).
   PubMed Web of Science ®Google Scholar
• Dartigues JF, Gagnon M, Michel P et al. The Paquid research program on the epidemiology of dementia. Methods and initial results. Rev. Neurol. (Paris)147, 225–230 (1991).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bonaiuto S, Lippi A et al. Prevalence of clinically diagnosed Alzheimer’s disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology40, 626–631 (1990).
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Grut M, Forsell Y et al. Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology41, 1886–1892 (1991).
   PubMed Web of Science ®Google Scholar
• Shigeta M. Epidemiology: rapid increase in Alzheimer’s disease prevalence in Japan. Psychogeriatrics4, 117–119 (2004).
   Google Scholar
• White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese–American men in Hawaii: the Honolulu–Asia Aging Study. JAMA276, 955–960 (1996).
   PubMed Web of Science ®Google Scholar
• Graves AB, Larson EB, Edland SD et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am. J. Epidemiol.144, 760–771 (1996).
   PubMed Web of Science ®Google Scholar
• Hou CE, Yaffe K, Perez-Stable EJ, Miller BL. Frequency of dementia etiologies in four ethnic groups. Dement. Geriatr. Cogn Disord.22, 42–47 (2006).
   PubMed Web of Science ®Google Scholar
• White L, Petrovitch H, Ross G et al. Brain aging and midlife tofu consumption. J. Am. Coll. Nutr.19, 242–255 (2000).
   PubMed Web of Science ®Google Scholar
• Reinwald S, Weaver CM. Soy isoflavones and bone health: a double-edged sword? J. Nat. Prod.69, 450–459 (2006).
   PubMed Web of Science ®Google Scholar
• Weaver CM, Cheong JM. Soy isoflavones and bone health: the relationship is still unclear. J. Nutr.135, 1243–1247 (2005).
   PubMed Web of Science ®Google Scholar
• Geller SE, Studee L. Soy and red clover for mid-life and aging. Climacteric9, 245–263 (2006).
   PubMed Web of Science ®Google Scholar
• Akaza H, Miyanaga N, Takashima N et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J. Clin. Oncol.34, 86–89 (2004).
   PubMed Web of Science ®Google Scholar
• Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol. Reprod.70, 1188–1195 (2004).
   PubMed Web of Science ®Google Scholar
• Rice S, Whitehead SA. Phytoestrogens and breast cancer – promoters or protectors? Endocr. Relat. Cancer13, 995–1015 (2006).
   PubMed Web of Science ®Google Scholar
• Ju YH, Allred KF, Allred CD, Helferich WG. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis27, 1292–1299 (2006).
   PubMed Web of Science ®Google Scholar
• Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis27, 856–863 (2006).
   PubMed Web of Science ®Google Scholar
• Setchell KD. Assessing risks and benefits of genistein and soy. Environ. Health Perspect.114, A332–A333 (2006).
   PubMed Web of Science ®Google Scholar
• Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J. Natl Cancer Inst.98, 1275–1284 (2006).
   PubMed Web of Science ®Google Scholar
• Patisaul HB. Phytoestrogen action in the adult and developing brain. J. Neuroendocrinol.17, 57–64 (2005).
   PubMed Web of Science ®Google Scholar
• Lephart ED, Setchell KD, Lund TD. Phytoestrogens: hormonal action and brain plasticity. Brain Res. Bull.65, 193–198 (2005).
   PubMed Web of Science ®Google Scholar
• Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol.388, 507–525 (1997).
   PubMed Web of Science ®Google Scholar
• Taylor AH, Al-Azzawi F. Immunolocalisation of oestrogen receptor-β in human tissues. J. Mol. Endocrinol.24, 145–155 (2000).
   PubMed Web of Science ®Google Scholar
• Perez SE, Chen EY, Mufson EJ. Distribution of estrogen receptor α and β immunoreactive profiles in the postnatal rat brain. Brain Res. Dev. Brain Res.145, 117–139 (2003).
   PubMedGoogle Scholar
• Zhao L, Wu TW, Brinton RD. Estrogen receptor subtypes α and β contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res.1010, 22–34 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao L, Brinton RD. Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res.1172, 48–59 (2007).
   PubMed Web of Science ®Google Scholar
• Zhao L, Brinton RD. Estrogen receptor β as a therapeutic target for promotion of neurogenesis and prevention of neurodegeneration. Drug Dev. Res.66, 103–117 (2006).
   Web of Science ®Google Scholar
• Perez-Martin M, Salazar V, Castillo C et al. Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats. Exp. Gerontol.40, 450–453 (2005).
   PubMed Web of Science ®Google Scholar
• Burguete MC, Torregrosa G, Perez–Asensio FJ et al. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats. Eur. J. Neurosci.23, 703–710 (2006).
   PubMed Web of Science ®Google Scholar
• Schreihofer DA, Do KD, Schreihofer AM. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.289, R103–R108 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen Q, Brinton RD. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp. Biol. Med.227, 509–519 (2002).
   PubMed Web of Science ®Google Scholar
• Lund TD, West TW, Tian LY et al. Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci.2, 20 (2001).
   PubMed Web of Science ®Google Scholar
• Patisaul HB, Dindo M, Whitten PL, Young LJ. Soy isoflavone supplements antagonize reproductive behavior and estrogen receptor α- and β-dependent gene expression in the brain. Endocrinology142, 2946–2952 (2001).
   PubMed Web of Science ®Google Scholar
• Linford NJ, Dorsa DM. 17β-estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids67, 1029–1040 (2002).
   PubMed Web of Science ®Google Scholar
• Linford NJ, Yang Y, Cook DG, Dorsa DM. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther.299, 67–75 (2001).
   PubMed Web of Science ®Google Scholar
• Ostatnikova D, Celec P, Hodosy J, Hampl R, Zdenek P, Kudela M. Short-term soybean intake and its effect on steroid sex hormones and cognitive abilities. Fertil. Steril. (2007) (In Press).
   PubMed Web of Science ®Google Scholar
• Celec P, Ostatnikova D, Caganova M et al. Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol. Obstet. Invest.59, 62–66 (2005).
   PubMed Web of Science ®Google Scholar
• File SE, Jarrett N, Fluck E, Duffy R, Casey K, Wiseman H. Eating soya improves human memory. Psychopharmacology (Berl.)157, 430–436 (2001).
   PubMed Web of Science ®Google Scholar
• File SE, Hartley DE, Elsabagh S, Duffy R, Wiseman H. Cognitive improvement after 6 weeks of soy supplements in post-menopausal women is limited to frontal lobe function. Menopause12, 193–201 (2005).
   PubMed Web of Science ®Google Scholar
• Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol. Biochem. Behav.75, 721–729 (2003).
   PubMed Web of Science ®Google Scholar
• Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E,Bressel MA. Isoflavones and cognitive function in older women: the Soy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause10, 196–202 (2003).
   PubMed Web of Science ®Google Scholar
• Casini ML, Marelli G, Papaleo E, Ferrari A, D’Ambrosio F, Unfer V. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil. Steril.85, 972–978 (2006).
   PubMed Web of Science ®Google Scholar
• Kreijkamp-Kaspers S, Kok L, Grobbee DE et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA292, 65–74 (2004).
   PubMed Web of Science ®Google Scholar
• Ho SC, Chan AS, Ho YP et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause14, 489–499 (2007).
   PubMed Web of Science ®Google Scholar
• Fournier LR, Ryan Borchers TA, Robison LM et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J. Nutr. Health Aging11, 155–164 (2007).
   PubMed Web of Science ®Google Scholar
• Burow ME, Boue SM, Collins-Burow BM et al. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor α and β. J. Clin. Endocrinol. Metab.86, 1750–1758 (2001).
   PubMed Web of Science ®Google Scholar
• Cassidy A, Brown JE, Hawdon A et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr.136, 45–51 (2006).
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai P et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr.131, S1362–S1375 (2001).
   PubMed Web of Science ®Google Scholar
• Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis17, 271–275 (1996).
   PubMed Web of Science ®Google Scholar
• Huang MH, Luetters C, Buckwalter GJ et al. Dietary genistein intake and cognitive performance in a multiethnic cohort of midlife women. Menopause13, 621–630 (2006).
   PubMed Web of Science ®Google Scholar
• Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil. Steril.82, 145–148 (2004).
   PubMed Web of Science ®Google Scholar
• D’Anna R, Cannata ML, Atteritano M et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause92(8), 3068–3075 (2007).
   Google Scholar
• Atteritano M, Marini H, Minutoli L et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab.92(8), 3068–3075 (2007).
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Bentz EK, Leodolter S et al. Phytoestrogens in clinical practice: a review of the literature. Fertil. Steril.87(6), 1243–1249 (2007).
   PubMed Web of Science ®Google Scholar
• Morito K, Hirose T, Kinjo J et al. Interaction of phytoestrogens with estrogen receptors α and β. Biol. Pharm. Bull.24, 351–356 (2001).
   PubMed Web of Science ®Google Scholar
• Wu J, Oka J, Ezaki J et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause14(5), 866–874 (2007).
   PubMed Web of Science ®Google Scholar
• Frankenfeld CL, McTiernan A, Thomas WK et al. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas53, 315–324 (2006).
   PubMed Web of Science ®Google Scholar
• Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med.217, 335–339 (1998).
   PubMed Web of Science ®Google Scholar
• Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut flora. J. Nutr.36, 27–32 (2000).
   Web of Science ®Google Scholar
• McCarty MF. Isoflavones made simple – genistein’s agonist activity for the β-type estrogen receptor mediates their health benefits. Med. Hypotheses66, 1093–1114 (2006).
   PubMed Web of Science ®Google Scholar